Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP809045.RAavW9nUfLDNSZriy-ChNNVgou2ys5Ma7oUFQPWxoACuA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP809045.RAavW9nUfLDNSZriy-ChNNVgou2ys5Ma7oUFQPWxoACuA130_assertion type Assertion NP809045.RAavW9nUfLDNSZriy-ChNNVgou2ys5Ma7oUFQPWxoACuA130_head.
- NP809045.RAavW9nUfLDNSZriy-ChNNVgou2ys5Ma7oUFQPWxoACuA130_assertion description "[JAK2 and MPL mutations appear to exert a phenotype-modifying effect and are distinctly associated with polycythemia vera, essential thrombocythemia and primary myelofibrosis; the corresponding mutational frequencies are approximately 99, 55 and 65% for JAK2 and 0, 3 and 10% for MPL mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP809045.RAavW9nUfLDNSZriy-ChNNVgou2ys5Ma7oUFQPWxoACuA130_provenance.
- NP809045.RAavW9nUfLDNSZriy-ChNNVgou2ys5Ma7oUFQPWxoACuA130_assertion evidence source_evidence_literature NP809045.RAavW9nUfLDNSZriy-ChNNVgou2ys5Ma7oUFQPWxoACuA130_provenance.
- NP809045.RAavW9nUfLDNSZriy-ChNNVgou2ys5Ma7oUFQPWxoACuA130_assertion SIO_000772 20428194 NP809045.RAavW9nUfLDNSZriy-ChNNVgou2ys5Ma7oUFQPWxoACuA130_provenance.
- NP809045.RAavW9nUfLDNSZriy-ChNNVgou2ys5Ma7oUFQPWxoACuA130_assertion wasDerivedFrom befree-2016 NP809045.RAavW9nUfLDNSZriy-ChNNVgou2ys5Ma7oUFQPWxoACuA130_provenance.
- NP809045.RAavW9nUfLDNSZriy-ChNNVgou2ys5Ma7oUFQPWxoACuA130_assertion wasGeneratedBy ECO_0000203 NP809045.RAavW9nUfLDNSZriy-ChNNVgou2ys5Ma7oUFQPWxoACuA130_provenance.